Home » Topics » Regulatory » Patents

Patents
RSS

MALT1-targeting compounds synthesized by the Dana-Farber Cancer Institute and collaborators

June 5, 2018

Hepagene Therapeutics describes farnesoid X receptor agonists

June 5, 2018

Bayer Animal Health discovers anthelmintic compounds

June 5, 2018

Vanderbilt University synthesizes new mGlu4 receptor positive allosteric modulators

June 4, 2018

Bruton tyrosine kinase inhibitors divulged by Daewoong Pharmaceutical

June 4, 2018

Kyushu University patents EGFR inhibitors

June 4, 2018

Bristol-Myers Squibb presents integrin alpha-V antagonists

June 1, 2018

Cancer Research Technology discloses CDC7 inhibitors

June 1, 2018

Bayer identifies new TANK1/2 inhibitors

June 1, 2018

Roche divulges gamma-secretase inhibitors

June 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....